PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
BMP-7 1,112 Target Target BMP-4 1,255 169 0.14 -0.86 0.15 0.85
BAFF 1,240 Target Target BAFFR 44 33 0.14 -0.49 0.75 0.80
Androgen Receptor 12,918 Target Disease Prostate Cancer 71,064 4,112 0.14 -0.80 0.32 0.76
Tissue-Type Plasminogen Activator 5,020 Target Target Urokinase-Type Plasminogen Activator 3,939 603 0.14 -0.86 0.15 0.83
EPHB3 118 Target Target EPHB1 137 17 0.13 -0.87 0.14 0.87
BMP-6 386 Target Target BMP-2 3,889 163 0.13 -0.74 0.42 0.80
4-1BB Ligand 135 Target Target CD137 474 33 0.13 -0.84 0.24 0.84
CCL3 1,427 Target Target CXCL10 2,386 238 0.13 -0.87 0.17 0.83
Artemin 184 Target Target Enovin 3 3 0.13 -0.50 1.00 0.81
CCL5 2,002 Target Target CXCL9 1,016 180 0.13 -0.87 0.18 0.83
CXCL10/IP-10 114 Target Target CXCL4/PF4 9 4 0.12 -0.73 0.44 0.83
Bile Salt Export Pump 476 Target Target Multidrug Resistance-Associated Protein 2 462 57 0.12 -0.88 0.12 0.85
AMY2B 21 Target Target AMY1A 13 2 0.12 -0.87 0.15 0.87
CCL18 256 Target Target DC-CK1 22 9 0.12 -0.76 0.41 0.82
CCL3 1,427 Target Target CXCL2 750 123 0.12 -0.87 0.16 0.83
CCL2 3,560 Target Target CXCL2 750 192 0.12 -0.84 0.26 0.80
CEA 17,022 Target Target CA 15-3 898 437 0.11 -0.71 0.49 0.76
CRG-2 41 Target Target CRG-10 2 1 0.11 -0.70 0.50 0.83
CXCL10/IP-10 114 Target Target CXCL11 526 27 0.11 -0.85 0.24 0.82
Dihydropteroate Synthase 408 Target Target Dihydrofolate Reductase 5,563 166 0.11 -0.76 0.41 0.78
CCL2 3,560 Target Target CCL8 197 92 0.11 -0.72 0.47 0.78
CD1A 2,739 Target Target CD68 6,424 458 0.11 -0.88 0.17 0.80
CXCL10/IP-10 114 Target Target CXCL9 1,016 37 0.11 -0.81 0.32 0.81
Epidermal Growth Factor Receptor 24,772 Target Disease Non Small Cell Lung Cancer 28,563 2,827 0.11 -0.89 0.11 0.78
CD4 112,219 Target Disease Infection 766,637 30,996 0.11 -0.83 0.28 0.68
BD3 32 Target Target BD4 26 3 0.10 -0.90 0.12 0.86
Eotaxin 2,457 Target Target Eotaxin-3/CCL26 26 26 0.10 -0.19 1.00 0.77
BMX 185 Target Target BTK 1,263 49 0.10 -0.84 0.26 0.80
CCL2 3,560 Target Target CXCL9 1,016 190 0.10 -0.88 0.19 0.80
Ent2 108 Target Target Equilibrative Nucleoside Transporter 1 211 15 0.10 -0.89 0.14 0.84
CXCL9 1,016 Target Target CCL3 1,427 117 0.10 -0.90 0.12 0.82
CCN5 57 Target Target CYR61 539 17 0.10 -0.82 0.30 0.81
Ck-beta-11 4 Target Target Exodus-2 27 1 0.10 -0.85 0.25 0.84
EPHB4 329 Target Target EPHB2 385 34 0.10 -0.90 0.10 0.84
Ns3 3,189 Target Disease Hepatitis 163,842 2,173 0.10 -0.56 0.68 0.71
CCL4 5,638 Target Target CCL5 2,002 316 0.09 -0.89 0.16 0.79
ELC 355 Target Target Exodus-3 8 5 0.09 -0.61 0.62 0.79
EPHB4 329 Target Target EPHB3 118 18 0.09 -0.90 0.15 0.82
FABP3 134 Target Target FABP1 90 10 0.09 -0.91 0.11 0.84
Epigen 27 Target Target Epiregulin 291 8 0.09 -0.83 0.30 0.81
Mu Opioid Receptor 4,576 Target Target Opioid Receptor Mu 71 51 0.09 -0.53 0.72 0.76
CKMM 55 Target Target CKBB 57 5 0.09 -0.91 0.09 0.86
Eotaxin 2,457 Target Target Eotaxin-2/CCL24 19 19 0.09 -0.22 1.00 0.76
Mu Opioid Receptor 4,576 Target Drug Dpdpe 1,204 206 0.09 -0.89 0.17 0.79
CD1A 2,739 Target Target CD14 9,941 456 0.09 -0.89 0.17 0.77
CXCL7 76 Target Target CXCL3 145 9 0.09 -0.91 0.12 0.84
Epiregulin 291 Target Target beta-Cellulin 17 6 0.09 -0.80 0.35 0.80
Des (1-3) IGF-I 191 Target Target Des (1-6) IGF-II 18 5 0.09 -0.84 0.28 0.81
Epidermal Growth Factor Receptor 24,772 Target Disease Cancer 1,053,491 13,587 0.08 -0.67 0.55 0.66
CA 72-4 184 Target Target CA 15-3 898 34 0.08 -0.89 0.18 0.80